GlassScriptPhysician profile
Craig P Chase
NPI 1326021528
$1,490.37
in general payments reported to CMS, 2019-2025
40 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $327 · 2021: $157 · 2022: $152 · 2023: $114 · 2024: $352 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $213.77 | 2019-2025 | Farxiga, Breztri |
| Allergan, INC. | $103.95 | 2019 | |
| Lilly USA, LLC | $100.67 | 2020-2025 | Jardiance, Zepbound, Kisunla |
| Merck Sharp & Dohme LLC | $98.73 | 2019-2025 | Vaxneuvance, Enflonsia, Gardasil 9 |
| Abbvie INC. | $89.66 | 2022-2024 | |
| Glaxosmithkline, LLC. | $80.47 | 2019-2023 | Trelegy Ellipta |
| Pfizer INC. | $62.61 | 2020-2025 | |
| Novo Nordisk INC | $49.13 | 2019-2021 | |
| Amgen INC. | $48.47 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $38.71 | 2022-2025 | |
| Renalytix Ai, INC. | $38.28 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Bayer Healthcare Pharmaceuticals INC. | $38.03 | 2021-2023 | |
| Genentech USA, INC. | $36.65 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $31.27 | 2021-2023 | Spravato |
| Averitas Pharma INC. | $30.46 | 2024 | Qutenza |
Show all 38 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Chase listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.